SEC Info - Third Point LLC, et al. - ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

SEC Info℠

Home

Help

Please Sign In

Third Point LLC, et al. – ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

On: Tuesday, 5/22/07, at 4:30pm ET · Accession #: 899140-7-1037 · File #: 5-43256

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/22/07  Third Point LLC                   SC 13D/A               2:36K  PDL Biopharma, Inc.               Willkie Fa… Gallagher/FA
          Daniel S. Loeb
          Jason Aryeh
          Third Point Offshore Fund, Ltd.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 4                                       11     42K 
 2: EX-99.1     Letter to Pdli                                         5     22K

SC 13D/A — Amendment No. 4
Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Interest in Securities of the Issuer Material to be Filed as Exhibits Purpose of Transaction Schedule 13D Source and Amount of Funds or Other Consideration
1	1st Page - Filing Submission
"	Schedule 13D
6	Item 3. Source and Amount of Funds or Other Consideration
"	Item 4. Purpose of Transaction
7	Item 5. Interest in Securities of the Issuer
8	Item 7. Material to be Filed as Exhibits

SC 13D/A 1st Page of 11 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
 (Amendment No. 4)

Under the Securities Exchange Act of 1934*

 PDL BioPharma, Inc.
------------------------------------------------------------- 
(Name of Issuer)

 Common Stock, par value $0.01 per share
------------------------------------------------------------- 
(Title of Class of Securities)

 69329Y104
------------------------------------------------------------- 
 (CUSIP Number of Class of Securities)

Daniel S. Loeb
 Third Point LLC
 390 Park Avenue
New York, NY 10022
(212) 224-7400
------------------------------------------------------------- 
 (Name, Address and Telephone Number of Person
 Authorized to Receive Notices and Communications)

Copies to:
 Michael A. Schwartz, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
 New York, NY 10019-6099
(212) 728-8000

May 22, 2007
------------------------------------------------------------- 
 (Date of Event which Requires
Filing of this Schedule)

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this   
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box: [ ]                                                              

NOTE: Schedules filed in paper format shall include a signed original and five  
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other    
parties to whom copies are to be sent.                                          

* The remainder of this cover page shall be filled out for a reporting person's 
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

SC 13D/A 2nd Page of 11 TOC 1st Previous Next ↓Bottom Just 2nd
SCHEDULE 13D

------------------------------                              --------------------
CUSIP No. 69329Y104                                         Page 2 of 11 Pages  
------------------------------                              --------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

        Third Point LLC                                 I.D. #13-3922602
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Delaware                                                
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    11,400,000                                      
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

11,400,000      
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

11,400,000                                              
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

9.8%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 3rd Page of 11 TOC 1st Previous Next ↓Bottom Just 3rd
SCHEDULE 13D

------------------------------                              --------------------
CUSIP No. 69329Y104                                         Page 3 of 11 Pages  
------------------------------                              --------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Third Point Offshore Fund, Ltd.                         
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Cayman Islands                                          
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    7,339,400                                       
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

7,339,400       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

7,339,400                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

6.3%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 4th Page of 11 TOC 1st Previous Next ↓Bottom Just 4th
SCHEDULE 13D

------------------------------                              --------------------
CUSIP No. 69329Y104                                         Page 4 of 11 Pages  
------------------------------                              --------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Daniel S. Loeb                                          
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

United States                                           
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    11,400,000                                      
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

11,400,000      
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

11,400,000                                              
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

9.8%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

IN                                                      
----------- --------------------------------------------------------------------

SC 13D/A 5th Page of 11 TOC 1st Previous Next ↓Bottom Just 5th
SCHEDULE 13D

------------------------------                              --------------------
CUSIP No. 69329Y104                                         Page 5 of 11 Pages  
------------------------------                              --------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Jason Aryeh                                             
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

United States                                           
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

62,783          
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    0                                               
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     62,783                                          
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

0               
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

62,783                                                  
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

0.05%                                                   
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

IN                                                      
----------- --------------------------------------------------------------------

SC 13D/A 6th Page of 11 TOC 1st Previous Next ↓Bottom Just 6th
This Amendment No. 4 to Schedule 13D ("Amendment No. 4") amends the   
Schedule 13D filed on March 5, 2007 (as amended by Amendment No. 1 thereto filed
on March 21, 2007, Amendment No. 2 thereto filed on April 11, 2007, Amendment   
No. 3 thereto filed on April 18, 2007, and this Amendment No. 4, the "Schedule  
13D") and is being filed on behalf of Third Point LLC, a Delaware limited       
liability company (the "Management Company" or "Third Point"), Third Point      
Offshore Fund, Ltd., a Cayman Islands limited liability exempted company (the   
"Offshore Fund"), Daniel S. Loeb, an individual ("Mr. Loeb", and together with  
the Management Company and the Offshore Fund, the "Third Point Reporting        
Persons"), and Jason Aryeh, an individual ("Mr. Aryeh", and together with the   
Third Point Reporting Persons, the "Reporting Persons"). This Amendment No. 4   
relates to the common stock, par value $0.01 per share (the "Common Stock"), of 
PDL BioPharma, Inc., a Delaware corporation (the "Company").                    

     The Management Company is the investment manager or adviser to a variety of
hedge funds and managed accounts (such funds and accounts, including the        
Offshore Fund, the "Funds"). The Funds directly own the Common Stock to which   
this Schedule 13D relates, and Mr. Loeb and the Management Company may be deemed
to have beneficial ownership over such Common Stock by virtue of the authority  
granted to them by the Funds to vote and to dispose of the securities held by   
the Funds, including the Common Stock. Mr. Aryeh may be deemed to have          
beneficial ownership of the shares of Common Stock directly owned by JALAA      
Equities, LP ("JALAA") by virtue of his ability to vote and/or to dispose of the
securities held by JALAA, including the Common Stock.                           

Item 3.   Source and Amount of Funds or Other Consideration.                    

         Item 3 of the Schedule 13D is hereby amended and restated as follows:

    The Funds expended an aggregate of approximately $226,611,028 of their own
investment capital to acquire the 11,400,000 shares of Common Stock held by     
them. The Offshore Fund expended an aggregate of approximately $145,942,634 of  
its own investment capital to acquire its 7,339,400 shares of Common Stock.     
JALAA expended an aggregate of approximately $1,139,360 of its own investment   
capital to acquire the 62,783 shares of Common Stock that it holds.             

Item 4.   Purpose of Transaction.                                               

        Item 4 of the Schedule 13D is hereby amended by adding the following
thereto:                                                                        

   On May 22, 2007, Third Point sent a letter to the unconflicted members of
the Company's Board of Directors (the "Unconflicted Directors"), consisting of  
all members of the Board other than L. Patrick Gage, Ph.D., Chairman of the     
Board of the                                                                    

6 

SC 13D/A 7th Page of 11 TOC 1st Previous Next ↓Bottom Just 7th
Company, and Mark McDade, Chief Executive Officer of the Company. Among other   
things, Third Point's letter:                                                   

    (i)   advised the Unconflicted Directors of the results of Third
Point's investigation into several troubling management issues,                 

     (ii)  questioned the manner in which Dr. Gage and Mr. McDade have
screened communications between Third Point and the Board,                      

  (iii) expressed Third Point's willingness to present its views
directly to the Board at the earliest possible date,                            

    (iv)  reiterated the reasons why the Board should be expanded to
accommodate Third Point representatives on the Board, and                       

       (v)   expressed the hope that the Unconflicted Directors would draw
the tough but necessary conclusion that the Board should no longer support Mr.  
McDade as Chief Executive Officer of the Company.                               

        In addition, Third Point's letter called for the removal of Dr. Gage
as Chairman of the Board, in light of his efforts as chief apologist for Mr.    
McDade, and for the dismissal of Jeanmarie Guenot as Vice President, Corporate &
Business Development.                                                           

   The May 22 letter from Third Point was sent to the Unconflicted
Directors following receipt by Third Point of a letter from Dr. Gage on May 16, 
2007 and an unsatisfactory conference call the same day between representatives 
of Third Point and Dr. Gage and Mr. McDade. The conference call with Dr. Gage   
and Mr. McDade had been arranged after Third Point had sent to the full Board on
May 8, 2007 a private letter that, among other things, had reiterated Third     
Point's prior demands that the Board terminate Mr. McDade as Chief Executive    
Officer of the Company, add three shareholder representatives to the Board and  
retain an investment bank to explore strategic alternatives for the Company.    

   A copy of Third Point's May 22, 2007 letter is attached to this
Schedule 13D as an exhibit and incorporated herein by reference in its entirety.

Item 5.   Interest in Securities of the Issuer.                                 

       Items 5(a), 5(b) and 5(c) of the Schedule 13D are hereby amended by
the following:                                                                  

    (a) As of the date of this Amendment No. 4, the Management Company and Mr.
Loeb beneficially own 11,400,000 shares of Common Stock (the "Third Point       
Shares"). The Third Point Shares represent 9.8% of the 116,603,643 shares of    
Common Stock outstanding as of May 2, 2007, as reported in the Company's        
Quarterly Report on Form                                                        

7 

SC 13D/A 8th Page of 11 TOC 1st Previous Next ↓Bottom Just 8th
10-Q for the quarterly period ended March 31, 2007. The percentages used herein 
and in the rest of this statement are calculated based upon this number of      
outstanding shares.                                                             

As of the date of this Schedule 13D, the Offshore Fund directly       
beneficially owns 7,339,400 shares of Common Stock, representing 6.3% of the    
outstanding shares of Common Stock. None of the other individual Funds owns a   
number of shares of Common Stock representing more than 5% of such total.       

    (b) The Management Company and Mr. Loeb share voting and dispositive power
over the 11,400,000 shares of Common Stock held by the Funds. The Management    
Company, Mr. Loeb and the Offshore Fund share voting power and dispositive power
over the 7,339,400 shares of Common Stock held by the Offshore Fund. Mr. Aryeh  
has sole voting power and dispositive power over the 62,783 shares of Common    
Stock held by JALAA.                                                            

(c) Schedules A hereto sets forth certain information with respect to 
transactions by the Funds (at the direction of the Management Company and Mr.   
Loeb) in Common Stock since the most recent filing on Schedule 13D. Schedule B  
hereto sets forth certain information with respect to transactions by the       
Offshore Fund (at the direction of the Management Company and Mr. Loeb) in      
Common Stock since the most recent filing on Schedule 13D.                      

 All of the transactions set forth on Schedules A and B were effected in
open market transactions or, as indicated on Schedules A and B, through the     
exercise of call options held by the Funds. Except as set forth on Schedules A  
and B, since the most recent filing on Schedule 13D there were no transactions  
in the Common Stock or options to purchase Common Stock effected by any of the  
Management Company, Mr. Loeb, the Offshore Fund or Mr. Aryeh, nor, in the case  
of the Management Company and the Offshore Fund and to the best of their        
knowledge, any of their directors, executive officers, general partners or      
members.                                                                        

Item 7.   Material to be Filed as Exhibits.                                     

99.1.     Letter, dated May 22, 2007, from Third Point to Samuel Broder, M.D.,  
          Karen A. Dawes, Bradford S. Goodwin, Laurence Jay Korn, Ph.D., Richard
  Murray, Ph.D., and John S. Saxe, Esq., members of the Board of
Directors of the Company.                                   

[Signatures on following page]

8 

SC 13D/A 9th Page of 11 TOC 1st Previous Next ↓Bottom Just 9th
SIGNATURES

   After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,   
complete and correct.                                                           

Dated:  May 22, 2007                                                            

                         THIRD POINT LLC

                              By:  Daniel S. Loeb,
                                           Chief Executive Officer

                                By:  /s/ Justin Nadler
                                                --------------------------------
                                     Name:   Justin Nadler
                                        Title:  Attorney-in-Fact

                                         THIRD POINT OFFSHORE FUND, LTD.

                                       By:  Daniel S. Loeb, Director

                                  By:  /s/ Justin Nadler
                                                --------------------------------
                                     Name:   Justin Nadler
                                        Title:  Attorney-in-Fact

                        DANIEL S. LOEB

                                By:  /s/ Justin Nadler
                                                --------------------------------
                                     Name:   Justin Nadler
                                        Title:  Attorney-in-Fact

                         /s/ Jason Aryeh
                                             -----------------------------------
                     Jason Aryeh

[SIGNATURE PAGE TO AMENDMENT NO. 4 TO SCHEDULE 13D
WITH RESPECT TO PDL BIOPHARMA, INC.]

SC 13D/A 10th Page of 11 TOC 1st Previous Next ↓Bottom Just 10th
Schedule A
----------

(Transactions by the Funds in Common Stock
 since the most recent filing on Schedule 13D)

   Date           Transaction           Shares          Price Per Share($)
   ----           -----------           ------          ------------------

---------------- ------------------- ------------------ ------------------------
04/20/07             BUY*             1,250,000              17.50      
---------------- ------------------- ------------------ ------------------------
04/24/07             BUY               100,000               25.19      
---------------- ------------------- ------------------ ------------------------
04/24/07             BUY               96,400                25.30      
---------------- ------------------- ------------------ ------------------------
04/30/07             SELL              (89,500)              25.26      
---------------- ------------------- ------------------ ------------------------
04/30/07             BUY               89,500                25.26      
---------------- ------------------- ------------------ ------------------------
05/18/07             BUY*              200,000               17.50      
---------------- ------------------- ------------------ ------------------------
05/18/07             BUY**             203,600               20.00      
---------------- ------------------- ------------------ ------------------------

* Pursuant to the exercise of call options having a strike price of $17.50 per  
share.                                                                          

** Pursuant to the exercise of call options having a strike price of $20.00 per 
share.                                                                          

SC 13D/A Last Page of 11 TOC 1st Previous Next ↓Bottom Just 11th
Schedule B

(Transactions by the Offshore Fund in Common Stock
 since the most recent filing on Schedule 13D)

   Date           Transaction           Shares          Price Per Share($)
   ----           -----------           ------          ------------------

---------------- ------------------- ------------------ ------------------------
04/20/07             BUY*             1,095,300               17.50     
---------------- ------------------- ------------------ ------------------------
04/24/07             BUY                49,800                25.19     
---------------- ------------------- ------------------ ------------------------
04/24/07             BUY                62,100                25.30     
---------------- ------------------- ------------------ ------------------------
04/30/07             SELL              (14,000)               25.26     
---------------- ------------------- ------------------ ------------------------
05/18/07             BUY*              137,500                17.50     
---------------- ------------------- ------------------ ------------------------
05/18/07             BUY**             132,600                20.00     
---------------- ------------------- ------------------ ------------------------

* Pursuant to the exercise of call options having a strike price of $17.50 per  
share.                                                                          

** Pursuant to the exercise of call options having a strike price of $20.00 per 
share.

SC 13D/A	1st Page of 11	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	6th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13D/A	7th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13D/A	8th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13D/A	9th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 9th

SC 13D/A	10th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 10th

SC 13D/A	Last Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 11th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	5/22/07	1	9	4
	5/16/07	7		4, 8-K
	5/8/07	7		4, 8-K, SC 13D/A
	5/2/07	7		8-K, 8-K/A
	4/18/07	6		8-K, SC 13D/A
	4/11/07	6		4, 8-K, SC 13D/A
	3/31/07	8		10-Q, 13F-HR
	3/21/07	6		SC 13D/A
	3/5/07	6		SC 13D
				List all Filings

↑Top

Filing Submission 0000899140-07-001037 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Third Point LLC, et al. – ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

On: Tuesday, 5/22/07, at 4:30pm ET · Accession #: 899140-7-1037 · File #: 5-43256

Previous ‘SC 13D’: ‘SC 13D’ on 5/17/07 · Next: ‘SC 13D/A’ on 5/24/07 · Latest: ‘SC 13D’ on 2/13/24

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

SC 13D/A — Amendment No. 4Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

SC 13D/A — Amendment No. 4
Document Table of Contents